October Effect LTD Anavex Life Sciences Corp. Transaction History
October Effect LTD
- $90.7 Billion
- Q3 2025
A detailed history of October Effect LTD transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, October Effect LTD holds 245,221 shares of AVXL stock, worth $1.97 Million. This represents 2.41% of its overall portfolio holdings.
Number of Shares
245,221
Previous 116,546
110.41%
Holding current value
$1.97 Million
Previous $1.07 Billion
103.1%
% of portfolio
2.41%
Previous 1.3%
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
198Shares Held
32MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$51.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$41 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$16.2 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY973KShares$7.82 Million0.02% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $626M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...